TGF-β activity and expression of its receptors in B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 31, Issue 1-2, 1998, Pages 99-106

  Lagneaux, Laurence ^a   Delforge, Alain ^a   Bernier, Michel ^a   Stryckmans, Pierre ^a   Bron, Dominique ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Apoptosis; B CLL; Proliferation; Receptors; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; B CELL LEUKEMIA; CELL CYCLE G0 PHASE; CHRONIC LYMPHATIC LEUKEMIA; PRIORITY JOURNAL;

EID: 0031678840     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057589     Document Type: Article

References (25)

1. Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C., Binet, J. L. and the French Cooperative Group on CLL. (1991). B-cell chronic lymphocytic leukemia: present status and future directions. Blood, 78, 1901-1914.
2. Bancherau, J., Brière, F., Liu, Y. J. and Rousset, F. (1994). Molecular control of B lymphocyte growth and differentiation. Stem Cells, 12, 278-88.
3. Cohen, J. J., Duke, R. C., Fadok, V. A. and Sellins, K. S. (1992). Apoptosis and programmed cell death in immunity. Ann Rev Immunol, 10, 267-93.
4. Urashima, M., Ogata, A., Chauhan, D., Hatziyanni, M., Vidriales, M. B., Dedera, D. A., Schlossman, R. L. and Anderson, K. C. (1996) Transforming growth factor-β1: differential effects on multiple myeloma versus normal B-cells. Blood, 87, 1928-38.
5. Buske, C., Becker, D., Feuring-Buske, M., Hannig, H., Wuef, G., Schöfer, C., Hiddemann, W. and Wörmann, B. (1997). TGF-β inhibits growth and induces apoptosis in leukemic B cell precursors. Leukemia, 11, 386-92.
6. Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B. and Fauci, A. S. (1986). Transforming growth factor β is an important immunomodulatory protein for human B-lymphocytes. J Immunol. 137, 3855-60.
7. Smeland, E. B., Blomhoff, H. K., Holte, H., Ruud, E., Beiske, K., Funderud, S., Godai, T. and Ohlsson, R. (1997). Transforming growth factor β inhibits G1 to S transition but not activation of human B lymphocytes. Exp Cell Res, 171, 213-22.
8. Lagneaux, L., Delforge, A., Bron, D., Massy, M., Bernier, M. and Stryckmans, P. (1997). Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-β receptors. Br J Haematol, 97, 612-20.
9. Israels, L. G., Israel, S. J., Begleiter, A., Verbrug, L., Schwartz, L., Mowat, M. R. A. and Johnston, J. B. (1993). Role of transforming growth factor β in chronic lymphocytic leukemia. Leuk Res, 17, 81-7.
10. Douglas, R. S., Capocasale, R. J., Lamb, R. J., Nowell, P. C. and Moore, J. S. (1997). Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor β. Blood, 89, 941-7.
11. Lotz, M., Ranheim, E. and Kipps, T. J. (1994). Transforming growth factor β as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med, 179, 999-1004.
12. Moore, J. S., Capocasale, R. J., Fox, F. E., Lamb, R. J., Besa, E. C., Penziner, A. S. and Nowell, P. C. (1993). Response of CLL B-cells to transforming growth factor-beta reflects biological heterogeneity. Blood, 82, 573a (abstr).
13. Laiho, M., Weis, F. and Massagué, J. (1990). Concomitant loss of transforming growth factor-β receptor type I and type II in TGF-β resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem, 265, 18518-24.
14. Kumar, A., Rogers, T., Maizel, A. and Sharma, S. (1991). Loss of transforming growth factor beta-1 receptor and its effect on the growth of EBV-transformed human B-cells. J Immunol, 147, 998-1006.
15. Lin, H. Y. and Moustakas, A. (1994). TGF-β receptors: structure and function. Cell Mol Biol, 40, 337-49.
16. Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B. and Sporn, M. B. (1994). Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TFG-β. Proc Natl Acad Sci USA, 91, 8772-8776.
17. Baldwin, R. L., Friess, H., Yokoyama, M., Lopez, M. E., Kobrin, M. S., Buchler, M. W. and Korc, M. (1996). Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition, Int J Cancer, 67, 283-8.
18. Kadin, M. E., Cacaille-Coll, M. W., Gertz, R., Massagué, J., Cheifetz, J. and George, D. (1994). Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci, 91, 6002-6.
19. Lagneaux, L., Delforge, A., Bron, D., Bosmans, E. and Stryckmans, P. (1995). Comparative analysis of cytokines released by bone maroow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients. Leuk Lymphoma, 17, 127-33.
20. Nowell, P. C., Moore, J. S., Fox, F. E., Capocasale, R. J., Kant, J. A. and Besa, E. C. (1994). Richter's syndrome associated with loss of response to transforming growth factor-beta. Leukemia Res. 18, 85-89.
21. DeCoteau, J. F., Knaus, P. I., Yankelev, Haya, Reiss, M. D., Lowsky, R., Lodish, H. F. and Kadin, M. E. (1997). Loss of functional surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc Natl Acad Sci, 94, 5877-81.
22. Moore, J. S., Friedman, D. F., Silberstein, L. E., Besa, E. C. and Nowell, P. C. (1995). Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia. Crit Rev Oncol Hematol, 20, 141-64.
23. Lomo, J., Blomhoff, H.K., Beiske, K., Stokke, T. and Smeland, E. B. (1995). TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol, 154, 1634-43.
24. Ohta, S., Yanagihara, K. and Nagata, K. (1997). Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. Biochem J, 324, 777-82.
25. Chaouchi, N., Arvanitakis, L., Auffredou, M. T., Blanchard, D. A., Vazquez, A. and Sharma, S. (1995). Characterization of transforming growth factor-β1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene, 11, 1615-22.